Cargando…
Immune Immunomodulation in Coronavirus Disease 2019 (COVID-19): Strategic Considerations for Personalized Therapeutic Intervention
We are learning that the host response to severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2) infection is complex and highly dynamic. Effective initial host defense in the lung is associated with mild symptoms and disease resolution. Viral evasion of the immune response can lead to refrac...
Autores principales: | Hall, Mark W, Joshi, Ila, Leal, Luis, Ooi, Eng Eong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337699/ https://www.ncbi.nlm.nih.gov/pubmed/32604407 http://dx.doi.org/10.1093/cid/ciaa904 |
Ejemplares similares
-
Cytokine Storm and Immunomodulation in COVID-19
por: Rangappa, Pradeep
Publicado: (2021) -
Target product profile for a dengue pre-vaccination screening test
por: Fongwen, Noah, et al.
Publicado: (2021) -
Potential therapeutic options for coronavirus disease 2019: using knowledge of past outbreaks to guide future treatment
por: Lin, John, et al.
Publicado: (2020) -
Focus on coronavirus disease 2019 associated coagulopathy
por: Yang, Xiang-Hong, et al.
Publicado: (2020) -
Personal knowledge on novel coronavirus pneumonia
por: Kang, Han-Yu-Jie, et al.
Publicado: (2020)